EFMH
IMVT icon

E Fund Management (HK)’s Immunovant IMVT Stock Holding History

E Fund Management (HK)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.4K Buy
+541
New +$14K 0.01% 294

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

E Fund Management (HK)'s IMVT Position: Q1 2026 in Review

E Fund Management (HK) opened a new position in Immunovant (IMVT) in Q1 2026: 541 shares worth $13.4K. The stake represents 0.01% of the portfolio and ranks #294 among its holdings.

215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • E Fund Management (HK) held 541 shares of Immunovant worth $13.4K as of Q1 2026.
  • Immunovant was a new E Fund Management (HK) position in Q1 2026.
  • Immunovant made up 0.01% of E Fund Management (HK)'s portfolio in Q1 2026, its #294 holding.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on E Fund Management (HK)'s 13F filing for Q1 2026, filed 8 Apr 2026.